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Leicester, United Kingdom; and Boston, Massachusetts
O B J E C T I V E S The purpose of this study was to assess the functional signiﬁcance of cardiac
magnetic resonance (CMR) measures of left ventricular (LV) remodeling and myocardial perfusion
reserve (MPR) in patients with severe aortic stenosis (AS), without obstructive coronary artery disease.
B A C KG ROUND Measures of stenosis severity do not correlate well with exercise intolerance in AS.
LV remodeling in AS is associated with myocardial ﬁbrosis and impaired MPR. The functional signiﬁcance
and determinants of MPR in AS are unclear.
METHOD S Forty-six patients with isolated severe AS were prospectively studied before aortic valve
replacement. The following investigations were undertaken: cardiopulmonary exercise testing to
measure aerobic exercise capacity (peak VO2); CMR to assess left ventricular mass index (LVMI),
myocardial ﬁbrosis with late gadolinium enhancement (LGE), myocardial blood ﬂow (MBF), and MPR; and
transthoracic echocardiography to assess stenosis severity and diastolic function.
R E S U L T S Peak VO2 was associated with sex (  0.41), age (  0.32), MPR (  0.45), resting
MBF (  0.53), and septal transmitral ﬂow velocity to annular velocity ratio (E/E=) (  0.34), but
not with LVMI, LGE, or echocardiographic measures of AS severity. On stepwise regression analysis, only
MPR was independently associated with age- and sex-corrected peak VO2 (  0.46, p  0.001). MPR
was also inversely related to New York Heart Association functional class (p  0.001). Univariate
associations with MPR were sex (  0.38, p  0.02), septal E/E= (  0.30, p  0.03), peak aortic valve
velocity (  0.34, p  0.02), LVMI (  0.51, p  0.001), and LGE category (  0.46, p  0.002).
On multivariate analysis, LVMI and LGE were independently associated with MPR.
CONC L U S I O N S CMR-quantiﬁed MPR is independently associated with aerobic exercise capacity
in severe AS. LV remodeling appears to be a more important determinant of impaired MPR than stenosis
severity per se. Further work is required to determine how CMR assessment of MPR can aid clinical
management of patients with AS. (J Am Coll Cardiol Img 2012;5:182–9) © 2012 by the American
College of Cardiology Foundation
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he development of left ventricular hyper-
trophy (LVH) in aortic stenosis (AS) has
been regarded as a necessary physiological
adaptation to maintain wall stress and pre-
erve cardiac function. Left ventricular (LV) re-
odeling in AS is associated with a number of
etrimental pathophysiological sequelae: intersti-
ial fibrosis (1,2), diastolic dysfunction (3), and
educed myocardial perfusion reserve (MPR) (4).
here is marked variation in the extent of LVH
See page 190
in patients with severe AS (4,5). Experimental
models of pressure overload have shown that ani-
mals that do not have LVH are better able to
maintain ejection fraction (6). Furthermore, pa-
tients with critical AS, but without LVH, are less
likely to have heart failure than patients with LVH (5).
Cardiac magnetic resonance (CMR) is the ideal
noninvasive technique to study LV remodeling.
Left ventricular mass (LVM) and volumes, late
gadolinium enhancement (LGE) for the detection
of focal myocardial fibrosis, and MPR can be
quantified accurately in a single examination. Myo-
cardial fibrosis in AS is detected on LGE images in
27% to 62% of patients (1,7,8). The extent of LGE
correlates with, although underestimates the extent
of, interstitial fibrosis on myocardial biopsy (1,2)
and increases with LVM (1,7,8).
Peak oxygen consumption (VO2) is an objective
easure of exercise capacity and an independent
redictor of prognosis in chronic heart failure (9).
here is a paucity of studies in AS, although patients
ith moderate to severe asymptomatic AS who are
imited by symptoms on exercise testing do have lower
eak VO2 and cardiac index than those who are
limited by fatigue (10). Resting echocardiographic
measures of stenosis severity and ejection fraction do
not predict exercise capacity, although LVH and
diastolic dysfunction may be important (3,11). The
aim of the current study was to assess the importance of
CMR measured LVM, LGE, and MPR in relation to
peak VO2 in patients with isolated, severe AS.
M E T H O D S
Patient selection. Patients with severe AS listed for
aortic valve replacement (AVR) were prospectively
enrolled from a single tertiary center between Oc-
tober 2008 and April 2010. Inclusion criteria were
ages 18 to 85 years and isolated severe AS; defined
as one of the following: aortic valve area (AVA) 1 acm2, peak aortic velocity 4 m/s, or mean pressure
gradient 40 mm Hg. Exclusion criteria were
syncope; moderate/severe valve disease other than
AS, previous valve surgery, obstructive coronary
artery disease (50% luminal stenosis on angiogra-
phy), chronic obstructive pulmonary disease, atrial
fibrillation, inability to exercise, a CMR contrain-
dication, and estimated glomerular filtration rate
30 ml/min. The local research and ethics com-
mittee approved the study. All subjects gave written
informed consent before investigations, which were
performed on the same day, 48 h after discontinu-
ing -blockers.
Echocardiography. Transthoracic echocardiography
as performed using a Vivid 7 (GE Healthcare,
aukesha, Wisconsin) according to
merican Society of Echocardiography
uidelines (12). Tissue Doppler imaging
llowed calculation of the transmitral flow
elocity to annular velocity ratio (E/E=), a
easure of LV filling pressure (13). Anal-
sis was performed offline blinded to pa-
ient details using EchoPAC software
GE Healthcare). The mean of 3 readings
as used for each parameter.
Diastolic perfusion time and LV rate pressure
product. Resting diastolic perfusion time
DPT) was calculated as before (14). Myocar-
ial work was estimated by calculating the
esting left ventricular rate pressure product
LVRPP): (peak aortic pressure gradient 
ystolic blood pressure)  heart rate (HR).
Cardiopulmonary exercise testing. Symptom-
limited exercise testing was performed on a
bicycle ergometer using a 1-min ramp pro-
tocol with age- and sex-specific workloads.
A 12-lead electrocardiogram was monitored
continuously and blood pressure recorded
every 2 min. Expired ventilatory gases were
analyzed using an ErgoCard CPEX Test Station
(Medisoft, Dinant, Belgium) to determine peak VO2.
ll exercise tests were physician supervised with indi-
ations for termination, as previously published (15).
Cardiac magnetic resonance. CMR was performed
using a 1.5-T scanner (Siemens, Avanto, Erlangen,
Germany) with retrospective electrocardiographic
triggering and a 6-channel phased array cardiac coil.
Steady-state free precession cine images were ac-
quired in 4-, 3-, and 2-chamber views. Perfusion
images were acquired after pharmacological vasodila-
tion with adenosine, 140 g/kg/min, for 3 min and
uring data acquisition. A gadolinium-based contrast
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184Germany) was administered intravenously (0.05
mmol/kg) at 5 ml/s, followed by a 20-ml saline flush.
First-pass perfusion was assessed for 3 slices (basal,
mid, and apical) acquiring every heartbeat using a
saturation recovery gradient echo sequence. Rest im-
aging was performed approximately 10 min after stress
imaging with a further 0.05 mmol/kg of contrast. In
the intervening time, a stack of short-axis slices were
obtained using cine imaging covering the entire left
ventricle. A further 0.1 mmol/kg of contrast was given
to bring the total dose to 0.2 mmol/kg. At least 10
min after this, LGE images were obtained with the
use of an inversion-recovery prepared, segmented
gradient echo sequence, as previously described (16).
CMR analysis. Analysis was performed offline blinded
o patient details using QMass software, version 7.1
Medis, Leiden, the Netherlands). The LV contours
ere drawn manually and left ventricular end-diastolic
olume (LVEDV), LV end-systolic volume, stroke
olume, left ventricular ejection fraction (LVEF), and
nd-diastolic LVM were calculated. Values were in-
exed by body surface area, denoted by the suffix ‘I,’
or example, LVMI. Interobserver and intraobserver
ariability was calculated on 10 random datasets by 2
xperienced observers (C.D.S., G.P.M.). The epicar-
ium and endocardium were contoured on the perfusion
mages, along with a region of interest in the LV blood
ool, to generate signal intensity curves. The measured
rterial input, measured in arbitrary signal intensity units,
as converted to a curve of percent enhancement, by
ividing by the baseline signal-intensity, namely, the
ignal intensity in the blood pool before any contrast
nhancement. A calibration curve of effective contrast
Recruitment Data
er of patients approached, excluded, and recruited. AR  aortic
on; CMR  cardiac magnetic resonance; COPD  chronic obstruc-
nary disease; EF  ejection fraction; LGE  late gadoliniumT
ent.nhancement versus the contrast enhancement extrapo-
ated from the low R1 (contrast concentration) range was
alculated by numerical simulation, using the sequence
arameters, and a mean pre-contrast T1 value for blood
f 1,450 ms. This calibration curve was then inverted,
nd used for correction of the observed percent contrast
nhancement in the blood pool. Saturation correction
esulted, on average, in a 20% to 30% increase of the peak
ontrast enhancement of the arterial input function. The
rterial input function corrected for signal saturation was
sed for myocardial blood flow (MBF) quantification by
odel-independent deconvolution (17). Transmural
PR was calculated by dividing hyperemic MBF by
esting MBF. All MPR results refer to uncorrected
alues, although resting MBF results are also displayed
orrected for LVRPP. Two experienced observers
C.D.S., G.P.M.) qualitatively assessed the perfusion
mages for subendocardial perfusion defects (a visible
efect for5 heartbeats) and the LGE images for focal
brosis, categorized as present or absent. Additionally,
omputer-assisted planimetry was used to determine the
ass and percentage of enhanced myocardium 5 SD
bove the mean signal intensity of remote normal
yocardium.
Statistical analysis. The distributions of continuous
variables were assessed using graphical displays and
the Shapiro-Wilk test for normality. Values are
reported as mean  SD or median (interquartile
range) if the distribution was not normal. Septal
E/E=, lateral E/E=, and LGE (%LV mass) were
skewed and logarithmically transformed before re-
gression analysis. Statistical analysis was undertaken
using SPSS, version 16.0 (SPSS, Chicago, Illinois)
and SAS (SAS Institute, Cary, North Carolina).
Comparison of means of 2 groups was done with a
t test and 2 groups with 1-way analysis of vari-
ance. Linear regression investigated possible asso-
ciations of continuous outcome measures. Stepwise
selection methods were used to determine the most
important associations. Hyperemic MBF was ad-
justed for resting MBF (thereby assessing MPR) by
forcing resting MBF into the model before selec-
tion methods were applied. The same method was
used when adjusting peak VO2 for age and sex. All
values 0.05 were considered significant.
R E S U L T S
Population characteristics. Details of recruitment are
utlined in Figure 1. Demographic data for the 46
atients included in this report are presented inFigure 1.
The numb
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185Cardiopulmonary exercise data. One exercise test was
medically terminated because of angina associated
with a 20 mm Hg drop in systolic blood pressure.
here were no complications. Twenty-two patients
48%) were symptom limited, and the remainder were
imited by fatigue, including all 9 patients in New
ork Heart Association (NYHA) functional class I.
xercise data are presented in Table 2.
Cardiac magnetic resonance. Volumetric data and
GE images were available for all patients. Results are
isplayed in Table 2. Interobserver and intraobserver
ariability were as follows: LVM 5.2% and 4.9%,
VEDV 3.1% and 3%, LVEF 6.6% and 4.7%.
hirty-four patients had global subendocardial perfu-
ion defects. There was a wide range of LVMI and
PR, but all patients had normal or near normal
ystolic function (n  5, LVEF 45% to 50%; n  1,
LVEF 40% to 45%). LGE was present in 26 (56%)
patients, and except in the patient excluded, there
were no clear myocardial infarctions. Examples of
patients with variable LVM, LGE, and MPR are
shown in Figure 2.
Associations with exercise capacity. Univariate analyses
Table 1. Patient Characteristics
Age, yrs 66.2 9.3
Male/female 34/12
Body surface area, m2 1.92 0.21
Systolic blood pressure, mm Hg 131 20
Diastolic blood pressure, mm Hg 74 10
Resting heart rate, beats/min 69 12
ACEI/ARB 15 (33%)
Beta-blocker 18 (39%)
Statin 28 (61%)
Diabetes mellitus 10 (22%)
Hypertension 27 (59%)
Smoking
Former 29 (63%)
Current 3 (6%)
NYHA functional class, (n) I (9); II (32); III (5)
Echocardiography
Peak AV velocity, m/s 4.4 0.6
Mean PG, mm Hg 48.5 14.1
AVA/I, (cm2)/(cm2/m2) 0.86 0.22/0.45 0.13
LVRPP, mm Hg·beats/min·104 1.46 0.29
Resting DPT, s/min 37.9 3.1
Septal E/E= 13.7 (11.1–18.6)
Lateral E/E= 10.2 (7.2–14.0)
Values are mean  SD, n, or n(%).
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin-
receptor blocker; AV  aortic valve; AVA/I  aortic valve area/index; DPT 
diastolic perfusion time; E/E=  transmitral ﬂow velocity to annular velocity
ratio; LVRPP left ventricular rate pressure product; NYHA New York Heart
Association; PG  pressure gradient.and results from the stepwise model selection for peakVO2 are summarized in Table 3. Peak VO2 was higher
n men compared with women: 16.2  4.1 ml/kg/min
ersus 12.3  3.1 ml/kg/min, respectively (p  0.005),
and decreased with age (Fig. 3A). Peak VO2 was
nversely related to septal E/E= and resting MBF, and
orrelated with MPR ( 0.45, r2 0.2) (Fig. 3B), but
ot with resting MBF/LVRPP or hyperemic MBF.
nly MPR was independently associated with age- and
ex-corrected peak VO2 on stepwise analysis. Correction
for -blocker usage did not affect the significance of the
models.
Symptomatic status. NYHA functional class was asso-
iated with peak VO2, even after adjustment for age and
ex (0.4, p 0.002). Patients with higher NYHA
functional class had lower MPR (p  0.001) (Fig. 4),
despite no significant differences in AS severity between
groups. Adding NYHA functional class to the stepwise
regression for associations with peak VO2 had no effect
on the significance of MPR as the only independent
variable.
Associations with resting MBF and perfusion reserve.
Resting and hyperemic MBF were higher in women
than men (resting, 1.07  0.24 vs. 0.84  0.15, p 
0.001; hyperemic, 2.16  0.53 vs. 1.64  0.38, p 
Table 2. Cardiac Magnetic Resonance and
Cardiopulmonary Exercise Data
Cardiac magnetic resonance
LVMI, g/m2 69.6 17.7
LVEDVI, ml/m2 96.9 14.6
LVESVI, ml/m2 42.5 10.6
LVM/LVEDV, g/ml 0.72 0.15
LVEF, % 56.5 6.5
Stroke volume index, ml/m2 53.6 7.7
Maximum wall thickness, mm 13.2 2.5
Resting MBF, ml/min/g 0.90 0.20
Resting MBF/LVRPP, (ml/min/g)/
(mm Hg.beats/min.104)
0.60 0.14
Hyperemic MBF, ml/min/g 1.77 0.47
Hyperemic heart rate, beats/min 88 12
MPR (n  41) 2.03 0.55
LGE positive 26 (56%)
LGE, % (5 SD above remote) 1 (0–28)
LGE mass, g (5 SD above remote) 1.8 (0.8–4.8)
Cardiopulmonary exercise testing
Peak heart rate, % predicted 85 12
Rise in systolic blood pressure, mm Hg 39 23
Respiratory exchange ratio 1.09 0.1
Peak VO2, ml/kg/min 15.2 4.2
Values are mean  SD, n (%), or median interquartile range.
LGE  late gadolinium enhancement; LVEDV  left ventricular end-
diastolic volume; LVEDVI  left ventricular end-diastolic volume index; LVEF  left
ventricular ejection fraction; LVESVI  left ventricular end-systolic volume
index; LVM left ventricular mass; LVMI left ventricular mass index; MBF
myocardial blood ﬂow; MPR  myocardial perfusion reserve, VO2  volume
oxygen consumption; other abbreviation as in Table 1.
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1860.002). Resting MBF correlated with resting LVRPP
( 0.47, p 0.02) and was inversely related to DPT
(0.35, p 0.025). Sex and resting LVRPP were
ndependent associations with resting MBF.
MPR was inversely related to peak aortic valve
elocity, mean pressure gradient, CMR measures of
VH, LGE category, and septal E/E=. Results are
ummarized in Table 4. MPR was not related to
istory of smoking, diabetes, or hypertension. With
ll univariable associations, the best stepwise mul-
ivariate regression model contained LVMI and
GE category as independent associations. MPR
as reduced in patients with LGE (1.87  0.47 vs.
.24  0.58, p  0.031), and there was also an
inverse correlation between MPR and LGE scar
mass at 5 SD (  0.4, p  0.008).
D I S C U S S I O N
Determinants of resting MBF and MPR. Resting and
yperemic MBF were higher in women, as has been
ound previously (18). As reported by Rajappan et al.
4), we did not find that measures of AS severity or
Figure 2. Examples of Patients With Varying LV Remodeling
Cardiac magnetic resonance images: (i) short-axis cine end-diastole
enhancement (LGE) at same level as “i” (LGE marked with white arr
hyperemia; and (iv) during rest perfusion. Four male patients displa
point LGE, and reduced myocardial perfusion reserve (MPR [age 63
(AVA) 0.92 cm2, MPR 1.07, peak volume oxygen consumption (VO2)
LGE (age 65 years, LVMI 76 g/m2, AVA 0.79 cm2, MPR 1.59, peak VO
55 g/m2, AVA 0.99 cm2, MPR 2.30, peak VO2 18.5 ml/kg/min). (D) N
LGE (age 63 years, LVMI 66 g/m2, AVA 0.73 cm2, MPR 2.4, peak VO2VMI were related to resting MBF. Contrary to that ftudy, there was an association between resting MBF
nd estimated myocardial work (LVRPP), as has also
een shown in hypertrophic cardiomyopathy (18).
he results of MPR in this study are remarkably
onsistent with those from Rajappan’s similar cohort
f patients with severe AS before AVR (2.03  0.55
s. 1.90  0.60, respectively), considering that posi-
ron emission tomography was used in that report (4).
e have shown that aortic valve velocities/pressure
radients, measures of LVM, and, for the first time,
emale sex, LV filling pressure (septal E/E=), and
yocardial fibrosis (LGE), have univariate associa-
ions with MPR. Of these, LVMI and LGE appear
o be the most important. These findings are some-
hat different from those of Rajappan et al. (4), whose
esults suggested that AS severity and DPT were more
mportant determinants of MPR in severe AS. The
iscrepancies are likely due to the smaller numbers (20
s. 41), that positron emission tomography was used,
hat no LGE for fibrosis was performed, and that the
ajority of patients in the Rajappan study were
symptomatic (4). Given the modest correlations
iddle level (A, B, and C) and basal level (D); (ii) late gadolinium
); (iii) perfusion imaging in middle left ventricular (LV) slice during
: (A) Signiﬁcantly raised left ventricular mass (LVM), clear insertion
rs, left ventricular mass index (LVMI) 126 g/m2, aortic valve area
7 ml/kg/min). (B) Mildly elevated LVM with mild insertion point
.4 ml/kg/min). (C) Normal LVM with no LGE (age 65 years, LVMI
al LVM with mild insertion point LGE but more signiﬁcant remote
6 ml/kg/min).at m
ows
yed
yea
12.
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ormound in our study, we cannot exclude that the
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187findings may be spurious; however, they are physio-
logically plausible. The lack of association between
smoking, hypertension, and diabetes (19) and MPR in
this study is almost certainly due to the smaller sample
size and the large effect of LV remodeling in these
patients with AS.
This is the first study to demonstrate the impor-
tance of myocardial fibrosis (LGE) in relation to
MPR in AS. This association may be explained by
reduced arteriolar and capillary density seen with
LV remodeling and fibrosis (20) and loss of the
“suction” wave seen in patients with LVH (21). It is
important to emphasize that diffuse myocardial
fibrosis (22) was not assessed (as newer T1-
mapping techniques were not available to us at the
time), and this may be an important determinant of
MPR. However, the extent of LGE does correlate
with diffuse fibrosis on myocardial biopsy (1).
Associations with exercise capacity. We hypothesized
hat CMR measures of LV remodeling would be
ndependently associated with aerobic exercise capac-
ty. As previously demonstrated, measures of AS
everity did not predict exercise capacity (15). Septal
/E=, resting MBF and MPR, but not measures of
VH, had univariate associations with peak VO2.
Table 3. Associations With Peak VO2
Univariate Associations
 p Value
Sex 0.41 0.005
Age 0.32 0.03
Peak AV velocity 0.18 0.24
Mean PG 0.18 0.24
AVAI 0.04 0.79
Septal E/E= 0.34 0.02
Lateral E/E= 0.23 0.13
LVMI 0.02 0.89
LVM/LVEDV ratio 0.04 0.79
LV maximum wall thickness 0.2 0.90
LVEF 0.01 0.97
LGE 0.05 0.73
Resting MBF 0.53 0.001
Resting MBF/LVRPP 0.28 0.08
Hyperemic MBF 0.01 0.94
MPR 0.45 0.004
Final Model (Stepwise Selection)
 p Value R2
Sex 0.44 0.002 0.42
Age 0.15 0.25
MPR 0.46 0.001
LV  left ventricular; other abbreviations as in Tables 1 and 2.nly MPR was independently associated with age-nd sex-corrected exercise capacity. This clinical study
as identified imaging and clinical parameters that
ave a clear and independent association with exercise
apacity in AS. Previous studies have suggested a
ange of parameters that include aortic valve compli-
nce (23–24), reduced longitudinal strain (25), LV
lling pressure (13) and diastolic dysfunction (3, 11).
owever, those studies have looked at exercise-
nduced symptoms, which may be subjective, as in our
tudy, where 50% of symptomatic patients were lim-
ted by fatigue, and they have not accounted for age
nd sex as determinants of exercise capacity. Many
ther factors may influence peak VO2, including
genetics, physical activity, and skeletal muscle
changes, which may be particularly important in
patients with cardiac dysfunction.
Mechanisms linking reduced myocardial perfusion
reserve and peak VO2. With exercise, cardiac output
ises incrementally with workload. Increased cardiac
Figure 3. Associations With Exercise Capacity
Relationship between peak volume oxygen consumption (VO2)
and (A) age and (B) myocardial perfusion reserve.
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188output in severe AS is largely dependent on increased
heart rate (26), which is associated with the develop-
ment of impaired MPR in both patients (27) and
experimental models of AS (28). The inability to
increase blood flow to the myocardium is limited
because vasodilation may already be near maximal
(29), DPT will be limited further with increased heart
rate, and there is a rapid increase in LV end-diastolic
pressure (26), which further reduces the effective
Figure 4. Perfusion Reserve and Symptomatic Status
Myocardial perfusion reserve and New York Heart Association
(NYHA) functional class. CI  conﬁdence interval.
Table 4. Associations With Perfusion Reserve
Univariate Associations
 p Value
Sex 0.38 0.02
Age 0.09 0.54
Hyperemic heart rate 0.2 0.19
Beta-blockers 0.008 0.96
LVRPP 0.1 0.58
Resting DPT 0.28 0.08
Peak AV velocity 0.34 0.02
Mean PG 0.30 0.04
AVAI 0.21 0.17
LVMI 0.51 0.001
LVM/LVEDV 0.43 0.003
LV maximum wall thickness 0.41 0.005
LVEF 0.28 0.07
LGE 0.46 0.002
Septal E/E= 0.33 0.03
Lateral E/E= 0.19 0.20
Final Model (Stepwise Selection)
 p Value R2
LVMI 0.40 0.004 0.43
LGE 0.31 0.02Abbreviations as in Tables 1, 2, and 3.pressure gradient for perfusion. Patients unable to
increase blood flow to the myocardium on exercise will
likely develop subendocardial myocardial dysfunction
(25,28), which will limit cardiac output and contribute
to exercise intolerance.
Clinical implications. MPR is an important prognostic
arker in hypertrophic cardiomyopathy, predicting ad-
erse ventricular remodeling and clinical outcomes (30).
mpaired MPR could be a therapeutic target in AS
atients unable to have aortic valve intervention and in
atients with persistent symptoms after AVR. Tradi-
ional therapies targeting LV remodeling such as inhib-
tors of the renin-angiotensin-aldosterone system and
rugs with novel mechanisms of action, for example,
erhexilene, may be useful in this context. The impor-
ance of impaired MPR to the development of symp-
oms and outcome in asymptomatic patients with AS
arrants further investigation.
Study limitations. The results of this mechanistic
tudy may not be applicable to the wider AS popula-
ion. Although we have touched on symptomatic
tatus in this paper, the number of asymptomatic
atients is small and, therefore, limited conclusions
an be drawn about this group. The cross-sectional
ature of our data does not allow one to draw
onclusions as to whether myocardial fibrosis leads to
reduction in MPR or if the reduced MPR causes
yocardial fibrosis. Longitudinal studies in patients
ith less severe AS with assessment of diffuse fibrosis
ay be able to answer this question. The reproduc-
bility of MPR measurements in AS is unknown.
inally, because of the relatively small numbers, the
umber of variables that can be appropriately used in
he multivariate regression analysis is necessarily lim-
ted. Therefore, we limited the number of univariate
ssociations entered into the multivariate model to 5
nd used the strongest univariate associations, avoid-
ng overlapping variables.
C O N C L U S I O N S
We have shown for the first time that MPR is
independently associated with objectively measured
exercise capacity in severe AS. Impaired MPR is
determined by a combination of factors including
AS severity, LV remodeling, and filling pressure.
Further work is required to determine how CMR
assessment of MPR can aid the clinical manage-
ment of patients with AS.
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